Apg10p, a novel protein-conjugating enzyme essential for autophagy in yeast.

Department of Cell Biology, National Institute for Basic Biology, Okazaki 444-8585, Japan.
The EMBO Journal (Impact Factor: 10.43). 11/1999; 18(19):5234-41. DOI: 10.1093/emboj/18.19.5234
Source: PubMed


Autophagy is a cellular process for bulk degradation of cytoplasmic components. The attachment of Apg12p, a modifier with no significant similarity to ubiquitin, to Apg5p is crucial for autophagy in yeast. This reaction proceeds in a ubiquitination-like manner, and requires Apg7p and Apg10p. Apg7p exhibits a considerable similarity to ubiquitin-activating enzyme (E1) and is found to activate Apg12p with ATP hydrolysis. Apg10p, on the other hand, shows no significant similarity to other proteins whose functions are known. Here, we show that after activation by Apg7p, Apg12p is transferred to the Cys-133 residue of Apg10p to form an Apg12p-Apg10p thioester. Cells expressing Apg10p(C133S) do not generate the Apg12p-Apg5p conjugate, which leads to defects in autophagy and cytoplasm-to-vacuole targeting of aminopeptidase I. These findings indicate that Apg10p is a new type of protein-conjugating enzyme that functions in the Apg12p-Apg5p conjugation pathway.

Download full-text


Available from: Takeshi Noda
  • Source
    • "In this system, the C-terminal glycine of Atg12 is covalently attached to Atg5 through an internal lysine residue. This process requires the action of Atg7 (E1 enzyme) [88] and Atg10 (E2 enzyme) ([89]. A third protein, Atg16, binds to the Atg5 component of the Atg12-Atg5 conjugate and dimerizes to link a pair of Atg12-Atg5 conjugates. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autophagosomes are double-membrane vesicles characteristic of macroautophagy, a degradative pathway for cytoplasmic material and organelles terminating in the lysosomal or vacuole compartment for mammals and yeast, respectively. This highly dynamic, multi-step process requires significant membrane reorganization events at different stages of the macroautophagic process. Such events include exchange and flow of lipids and proteins between membranes and vesicles (e.g., during initiation and growth of the phagophore), vesicular positioning and trafficking within the cell (e.g., autophagosome location and movement) and fusion of autophagosomes with the boundary membranes of the degradative compartment. Here, we review current knowledge on the contribution of different organelles to the formation of autophagosomes, their trafficking and fate within the cell. We will consider some of the unresolved questions related to the molecular mechanisms that regulate the "life and death" of the autophagosome.
    Full-text · Article · Dec 2012 · International Journal of Molecular Sciences
  • Source
    • "Autophagy is a genetically programmed, evolutionarily conserved process coordinated by a family of genes, called Atg, that lead to the degradation of organelles and proteins. It involves the formation of double-membrane vesicles, containing cellular components, that merge to lysosomes, forming the autophagolysosome, where the components are degraded and the products generated are reused by the cell [40], [41]. In this view, autophagy acts as a prosurvival mechanism, mainly in adverse conditions such as nutrient and oxygen deprivation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Prognosis of patients with glioblastoma (GBM) remains very poor, thus making the development of new drugs urgent. Resveratrol (Rsv) is a natural compound that has several beneficial effects such as neuroprotection and cytotoxicity for several GBM cell lines. Here we evaluated the mechanism of action of Rsv on human GBM cell lines, focusing on the role of autophagy and its crosstalk with apoptosis and cell cycle control. We further evaluated the role of autophagy and the effect of Rsv on GBM Cancer Stem Cells (gCSCs), involved in GBM resistance and recurrence. Glioma cells treated with Rsv was tested for autophagy, apoptosis, necrosis, cell cycle and phosphorylation or expression levels of key players of these processes. Rsv induced the formation of autophagosomes in three human GBM cell lines, accompanied by an upregulation of autophagy proteins Atg5, beclin-1 and LC3-II. Inhibition of Rsv-induced autophagy triggered apoptosis, with an increase in Bax and cleavage of caspase-3. While inhibition of apoptosis or autophagy alone did not revert Rsv-induced toxicity, inhibition of both processes blocked this toxicity. Rsv also induced a S-G2/M phase arrest, accompanied by an increase on levels of pCdc2(Y15), cyclin A, E and B, and pRb (S807/811) and a decrease of cyclin D1. Interestingly, this arrest was dependent on the induction of autophagy, since inhibition of Rsv-induced autophagy abolishes cell cycle arrest and returns the phosphorylation of Cdc2(Y15) and Rb(S807/811), and levels of cyclin A, and B to control levels. Finally, inhibition of autophagy or treatment with Rsv decreased the sphere formation and the percentage of CD133 and OCT4-positive cells, markers of gCSCs. In conclusion, the crosstalk among autophagy, cell cycle and apoptosis, together with the biology of gCSCs, has to be considered in tailoring pharmacological interventions aimed to reduce glioma growth using compounds with multiple targets such as Rsv.
    Full-text · Article · Jun 2011 · PLoS ONE
  • Source
    • "The vesicle elongation and completion process requires two ubiquitin-like pathways involving two ubiquitin-like proteins, Atg12 and Atg8 proteins, respectively. The first pathway includes an Atg12-Atg5 covalently conjugating system, and subsequently the formation of which requires an E1- and E2- like proteins Atg7 and Atg10, respectively21, 22, 23. In mouse, the Atg12-Atg5 conjugate interacts with a small coiled-coil protein, Atg16L (an ortholog of Atg 16 in yeast), to form an Atg12-Atg5-Atg16L complex. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Autophagy is an evolutionarily conserved lysosomal self-digestion process involved in degradation of long-lived proteins and damaged organelles. In recent years, increasing evidence indicates that autophagy is associated with a number of pathological processes, including cancer. In this review, we focus on the recent studies of the evolutionarily conserved autophagy-related genes (ATGs) that are implicated in autophagosome formation and the pathways involved. We discuss several key autophagic mediators (eg, Beclin-1, UVRAG, Bcl-2, Class III and I PI3K, mTOR, and p53) that play pivotal roles in autophagic signaling networks in cancer. We discuss the Janus roles of autophagy in cancer and highlighted their relationship to tumor suppression and tumor progression. We also present some examples of targeting ATGs and several protein kinases as anticancer strategy, and discuss some autophagy-modulating agents as antitumor agents. A better understanding of the relationship between autophagy and cancer would ultimately allow us to harness autophagic pathways as new targets for drug discovery in cancer therapeutics.
    Preview · Article · Sep 2010 · Acta Pharmacologica Sinica
Show more